Week of January 9 – 13, 2017
OUHSC DEPARTMENT OF MEDICINE CONFERENCE SCHEDULE
NOTE: All CME conferences will be designated by an * by the name of the conference.
Monday, January 9, 20177:30 – 8:30 AM Cath Mortality & Morbidity Conference: AAT 5200
12:00 – 1:00 PM Cardiology Fellows Conference: “EKG Conference,” Ali F. Yousif, MD, Cardiovascular Fellow. AAT 5200
12:15 – 1:00 PM Medicine House Staff Conference: Case Report. AAT Conf Rm A&B
12:15 – 1:15 PM Pulmonary and Critical Care Conference: Section Meeting. AAT 8200
Tuesday, January 10, 20177:00 – 8:00 AM Cardiology Cath Conference: “Percutaneous Coronary Intervention Complications,” Mazen Abu-Fadel, MD, Associate Professor, Department of Medicine/Cardiovascular. AAT 5200
8:00 – 9:00 AM Endocrinology Grand Rounds: “Case Conference,” Camille Folkard, MD, Endocrinology Fellow. HHDC 2923
Objectives: Upon completion of this session, participants will improve their competence and performance by being able to: Recognize challenging patient cases encountered in the inpatient and/or outpatient setting. Review different treatment options available for the management of these cases.
12:15 – 1:15 PM *Medical Grand Rounds: Papper Lecture – “Cirrhosis – From Bench to Bedside,” Don C. Rockey, MD, Professor and Chairman, Department of Internal Medicine, Medical University of South Carolina. SEC Rainbolt Auditorium. (1.0 AMA PRA Category 1 Credit™).
Objectives: Upon completion of this session, participants will improve their competence and performance by being able to: Develop an understanding of the pathogenesis of liver fibrosis and cirrhosis. Identify potential treatments and novel treatments for cirrhosis. Recognize that cirrhosis may be reversible, and understand issues around management of patients with potentially reversible cirrhosis.
Speaker Disclosures: Dr. Rockey has no relevant financial relationships or affiliations with commercial interests to disclose.
7:00 – 8:00 AM Vascular Conference: AAT 9200
7:30 – 8:30 AM CICU Case Conference: AAT 5200
8:15 – 9:00 AM ID Journal Club: AAT Conf Rm C
12:15 – 1:00 PM Medicine House Staff Conference: Case Report. AAT Conf Rm A&B
12:15 – 1:15 PM Pulmonary and Critical Care Conference: Core Conference – “Pre-operative Pulmonary Evaluation of Patients with Chronic Lung Disease or OSA,” Tony Abdo, MD, Pulmonary Fellow. AAT 8200
1:30 – 2:30 PM Renal Grand Rounds: Case Consultation: VAMC 5E108
1:30 – 3:00 PM Rheumatology Clinical Conference: “Radiology,” Jennifer Hinkle, MD, Department of Radiological Sciences, VAMC. OMRF PV302
3:00 – 4:00 PM Digestive Disease and Nutrition Conference: “Celiac Disease: Pathophysiology and Diagnostic Testing,” Molly B. Disbrow, MD, Digestive Disease Fellow and Mohammad Madhoun, MD, Assistant Professor, Department of Medicine/Digestive Disease. SEC 3rd Fl Conf Rm
4:00 – 5:00 PM Pulmonary Sleep Conference: “Journal Club,” Barbara Carlson, RN, PhD, Professor, Nursing Academic Programs. SEC Basement, Room A
Department of Medicine Conference Schedule January 9 - 13, 2017
Thursday, January 12, 20177:00 – 8:00 AM GI Journal Club: AAT 7200
7:30 – 8:30 AM *Cardiovascular Grand Rounds: “TBA,” Federico Silva-Palacios, MD, Assistant Professor, Department of Medicine/Cardiovascular. AAT 1st Floor Conf Rm C
11:00 – 12:00 PM OMRF Research Forum: “Regulating Destruction to Recombine the Genome,” Neil Hunter, PhD, Howard Hughes Medical Institute, Department of Microbiology & Molecular Genetics, University of California Davis. OMRF Ben C. Wileman Learning Center. Lunch provided after the lecture.
12:15 – 1:00 PM Medicine House Staff Conference: “Pain Management in Older Adults,” Eugene Steinberg, MD, Assistant Professor, Department of Geriatrics. SEC, 3rd Fl Conf Rm
12:15 – 1:15 PM Pulmonary and Critical Care Conference: Core Conference – “Hypersensitivity Pneumonitis,” Jad Kebbe, MD, Assistant Professor, Department of Medicine/Pulmonary. AAT 8200
Friday, January 13, 20177:30 – 8:30 AM Echocardiography Conference: AAT 5200
8:00 – 9:00 AM Hematology/Oncology Grand Rounds Conference: “TBA,” Andrew Artz, MD, Associate Professor of Medicine, the University of Chicago Medicine. SCC 6039
8:30 – 9:30 AM Renal Journal Club: AAT 5328
12:15 – 1:00 PM Medicine House Staff Conference: Chief Session. SEC 3rd Fl Conf Rm
12:15 – 1:15 PM Pulmonary and Critical Care Conference: Core Conference – “Thoracic Imaging,” Ahmed Awab, MD, Assistant Professor, Department of Medicine/Pulmonary. AAT 8200
1:30 – 2:30 PM Combined Thoracic-Oncology Clinical Care Conference: VAMC 5F-121
For accommodations on the basis of disability, call 405-271-6655 x1.
FUTURE EVENTS
January 16th Martin Luther King Jr. Day 2017
Check out the Internet listing of grand rounds and seminars at: http://www.ouhsc.edu/insidehsc/
To place name on mailing list or provide input for future schedules, contact Ms. Brenda Wilkerson, Department of Medicine. Schedules are typically e-mailed on Thursday of the week prior to the week of listed activities. If you wish to receive this via e-mail, you may use the Internet to request it. Address:
Accreditation Statement: The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Oklahoma College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Conflict Resolution Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.
Acknowledgement of Commercial and In-Kind Support: This activity has received in-kind support from the State of Oklahoma – University Hospitals Authority & Trust.
Planning Committee Members:
Course Director – Michael Bronze, MD
Course Contact – Brenda Wilkerson
Planning Committee – Adam Asch, MD, Brent Brown, MD, Benjamin Cowley, Jr, MD, Douglas Drevets, MD, Courtney Houchen, MD, Mary Beth Humphrey, MD, PhD, Rhett Jackson, MD, James Lane, MD, Dwight Reynolds, MD
Nondiscrimination Statement: The University of Oklahoma, in compliance with all applicable federal and state laws and regulations does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, and educational services.
Accommodation Statement: For accommodations on the basis of disability, call: 271-6655 x1.
Policy on Faculty and Presenter Disclosure: It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Disclaimer Statement: Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.
Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.
Disclosure & Resolution ReportThe University of Oklahoma College of Medicine and the Irwin H. Brown Office of Continuing Professional Development must ensure balance, independence, objectivity and scientific rigor in all its activities. We have implemented a process where everyone who is in a position to control the content of an educational activity has disclosed to us all relevant financial relationships with any commercial interest. In addition, should it be determined that a conflict of interest exists as a result of a financial relationship one may have, this will be resolved prior to the activity. This policy is designed to provide the target audience with an opportunity to review any affiliations between the CME organizers/presenters and supporting organizations for the purpose of determining the potential presence of bias or influence over educational content. The following is a summary of this activities disclosure information.
Nature of Relevant Financial Relationship
Role / First Name / Last Name / Commercial Interest / What was received? / For what role?
Course Director/Moderator / Michael / Bronze, MD / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Course Contact / Brenda / Wilkerson / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Planning Committee /Moderator / Adam / Asch, MD / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Planning Committee /Moderator / Brent / Brown, MD / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Planning Committee /Speaker/Moderator / Benjamin / Cowley, Jr, MD / COARE Biotechnology / Grants/Research / Co-Founder
Planner: The conflict was resolved by Dr. Cowley agreeing to recuse himself from planning content in the conflicted area. Speaker: The conflict was resolved by Dr. Cowley agreeing that the presentation(s) will not include discussion of any products or services from the commercial interests and he will refrain from making clinical recommendations on topics in which the conflict exists. Moderator: The conflict was resolved by Dr. Cowley agreeing to limit his role to the introduction of presenters, fielding questions and moderating the flow of discussion between participants and presenters.
Planning Committee /Moderator / Douglas / Drevets, MD / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Planning Committee /Moderator / Courtney / Houchen, MD / COARE Biotechnology / Grants/Research / Co-Founder
Planner: The conflict was resolved by Dr. Houchen agreeing to recuse himself from planning content in the conflicted area. Moderator: The conflict was resolved by Dr. Houchen agreeing to limit his role to the introduction of presenters, fielding questions and moderating the flow of discussion between participants and presenters.
Planning Committee /Moderator / Mary Beth / Humphrey / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Planning Committee /Moderator / Rhett / Jackson, MD / I have no relevant financial relationships or affiliations with commercial interests to disclose.
Planning Committee /Speaker / James / Lane, MD / EMD Serono, Inc / Pays HHDC / Clinical Trials Research
Merck/Pfizer / Pays HHDC / Clinical Trials Research
Merck Sharp & Dohme Corp / Pays HHDC / Clinical Trials Research
Novo Nordisk / Pays HHDC / Clinical Trials Research
Planner: Dr. Lane has recused himself from planning content in the conflicted areas. Speaker: The conflict was resolved by Dr. Lane agreeing that the presentation(s) will not include discussion of any products or services from the commercial interest.
Planning Committee /Speaker/Moderator / Dwight / Reynolds, MD / Medtronic, Inc / Honorarium / Speaker, Advisory Board
Medtronic, Inc / Research Funding / Primary Investigator
Sorin, Inc / Honorarium / Advisory Board Member
Planner: The conflict was resolved by Dr. Reynolds agreeing to recuse himself from planning content in the conflicted areas. Speaker: The conflict was resolved by Dr. Reynolds agreeing that the presentation(s) will not include discussion of any products or services from the commercial interests and he will refrain from making clinical recommendations on topics in which the conflict exists. Moderator: The conflict was resolved by Dr. Reynolds agreeing to limit his role to the introduction of presenters, fielding questions and moderating the flow of discussion between participants and presenters.